Pricing Log in Create free account
Friday 6 November 2026 Export ILMN’s income statement to Excel — free account

Illumina, Inc.

ILMN Healthcare Diagnostics & Research

Illumina, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 0.66% from fiscal 2024.

Revenue
+4.15%
EPS
+49.0%
Free cash flow
+49.8%
Total debt
+80.0%

Quarter to September 2026, against a year earlier

213.71 5.71 +2.75%
Market cap
$31.5B
P/E
35.6×
Fwd P/E
46.4×
Dividend yield
—
F-score
8/9
Altman Z
4.39
Beneish M
−2.51
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Illumina, Inc. (ILMN) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
10-Q Sep 27, 2026 P1I2: no comparison — the Item was not found
P2I1A: no comparison — the Item was not found
8-K Oct 29, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Oct 13, 2026 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
8-K Aug 17, 2026 8.01 Other events; 9.01 Financial statements and exhibits
8-K Aug 13, 2026 1.01 Entry into a material definitive agreement; 1.02 Termination of a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
8-K Aug 10, 2026 8.01 Other events; 9.01 Financial statements and exhibits
8-K Aug 7, 2026 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Jun 28, 2026 P1I2: no comparison — the Item was not found
P2I1A: no comparison — the Item was not found
8-K Jul 30, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jun 16, 2026 5.02 Departure or appointment of directors or officers Officer departure
8-K May 21, 2026 5.07 Submission of matters to a vote of security holders; 9.01 Financial statements and exhibits
10-Q Mar 29, 2026 P1I2: no comparison — the Item was not found
P2I1A: no comparison — the Item was not found
8-K Apr 30, 2026 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Apr 2, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-K Dec 28, 2025 1: no comparison — the earlier filing's Item cannot be compared
1A: no comparison — the earlier filing's Item cannot be compared
7: no comparison — the earlier filing's Item cannot be compared
8-K Feb 5, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 30, 2026 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Jan 13, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 8, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Nov 25, 2025 8.01 Other events; 9.01 Financial statements and exhibits
8-K Nov 10, 2025 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Sep 28, 2025 P1I2: no comparison — the Item was not found
P2I1A: no comparison — the Item was not found
8-K Oct 30, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 29, 2025 P1I2: no comparison — the Item was not found
P2I1A: no comparison — the Item was not found
8-K Jul 31, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Mar 30, 2025
8-K May 8, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Dec 29, 2024 Impairment
8-K Feb 6, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 14, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Sep 29, 2024
8-K Nov 4, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2024
8-K Aug 6, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K May 2, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 8, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 9, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Nov 9, 2023 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.